Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7215072, 13 pages
https://doi.org/10.1155/2017/7215072
Review Article

Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis

1Centre LOEX de l’Université Laval, Génie Tissulaire et Régénération, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC, Canada
2Faculté de Pharmacie, Université Laval, Québec, QC, Canada
3L’Oréal Research & Innovation, Aulnay-sous-Bois, France
4Episkin Academy, Lyon, France

Correspondence should be addressed to Roxane Pouliot; ac.lavalu.ahp@toiluop.enaxor

Received 19 May 2017; Revised 15 September 2017; Accepted 2 October 2017; Published 8 November 2017

Academic Editor: Anna Balato

Copyright © 2017 Isabelle Lorthois et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. O. Nestle, D. H. Kaplan, and J. Barker, “Psoriasis,” The New England Journal of Medicine, vol. 361, no. 5, pp. 496–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Griffiths and J. N. Barker, “Pathogenesis and clinical features of psoriasis,” The Lancet, vol. 370, no. 9583, pp. 263–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Bernard, S. M. Robinson, S. Vandaele, J. N. Mansbridge, and M. Darmon, “Abnormal maturation pathway of keratinocytes in psoriatic skin,” The British Journal of Dermatology, vol. 112, no. 6, pp. 647–653, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. Bernard, A. Reano, Y. M. Darmon, and J. Thivolet, “Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin,” The British Journal of Dermatology, vol. 114, no. 3, pp. 279–283, 1986. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Bernard, D. Asselineau, L. Schaffar-Deshayes, and M. Y. Darmon, “Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program?” The Journal of Investigative Dermatology, vol. 90, no. 6, pp. 801–805, 1988. View at Publisher · View at Google Scholar
  6. F. Bernerd, T. Magnaldo, and M. Darmon, “Delayed onset of epidermal differentiation in psoriasis,” The Journal of Investigative Dermatology, vol. 98, no. 6, pp. 902–910, 1992. View at Publisher · View at Google Scholar
  7. M. Detmar, L. F. Brown, K. P. Claffey et al., “Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis,” The Journal of Experimental Medicine, vol. 180, no. 3, pp. 1141–1146, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Verschoore, C. Kowalewski, M. J. Chorzelska, B. A. Bernard, and Y. M. Darmon, “Intraepidermal leakage of plasma proteins after tape stripping of normal skin and uninvolved psoriatic skin,” The British Journal of Dermatology, vol. 122, no. 3, pp. 391–397, 1990. View at Publisher · View at Google Scholar
  9. Meier TO, L. Kovacicova, R. Huggenberger, A. A. Navarini, G. Gitzelmann, and B. R. Amann-Vesti, “Increased permeability of cutaneous lymphatic capillaries and enhanced blood flow in psoriatic plaques,” Dermatology, vol. 227, no. 2, pp. 118–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Parent, B. A. Bernard, C. Desbas, M. Heenen, and M. Y. Darmon, “Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology,” The Journal of Investigative Dermatology, vol. 95, no. 3, pp. 333–340, 1990. View at Publisher · View at Google Scholar
  11. A. Menter, A. Gottlieb, S. R. Feldman et al., “Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics,” Journal of the American Academy of Dermatology, vol. 58, no. 5, pp. 826–850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. C. Trembath, R. L. Clough, J. L. Rosbotham et al., “Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis,” Human Molecular Genetics, vol. 6, no. 5, pp. 813–820, 1997. View at Publisher · View at Google Scholar
  13. R. P. Nair, T. Henseler, S. Jenisch et al., “Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan,” Human Molecular Genetics, vol. 6, no. 8, pp. 1349–1356, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. D. Burden, S. Javed, M. Bailey, M. Hodgins, M. Connor, and D. Tillman, “Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p,” The Journal of Investigative Dermatology, vol. 110, no. 6, pp. 958–960, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. J. E. Gudjonsson, A. Johnston, H. Sigmundsdottir, and H. Valdimarsson, “Immunopathogenic mechanisms in psoriasis,” Clinical and Experimental Immunology, vol. 135, no. 1, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. T. Elder, R. P. Nair, S. W. Guo, T. Henseler, E. Christophers, and J. J. Voorhees, “The genetics of psoriasis,” Archives of Dermatology, vol. 130, no. 2, pp. 216–224, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Jarczak, E. M. Kosciuczuk, P. Lisowski et al., “Defensins: natural component of human innate immunity,” Human Immunology, vol. 74, no. 9, pp. 1069–1079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. J. Hollox, U. Huffmeier, P. L. Zeeuwen et al., “Psoriasis is associated with increased β-defensin genomic copy number,” Nature Genetics, vol. 40, no. 1, pp. 23–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. C. Tsoi, S. L. Spain, J. Knight et al., “Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity,” Nature Genetics, vol. 44, no. 12, pp. 1341–1348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. P. Jariwala, “The role of dendritic cells in the immunopathogenesis of psoriasis,” Archives of Dermatological Research, vol. 299, no. 8, pp. 359–366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Lande, J. Gregorio, V. Facchinetti et al., “Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide,” Nature, vol. 449, no. 7162, pp. 564–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. B. J. Nickoloff and F. O. Nestle, “Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities,” The Journal of Clinical Investigation, vol. 113, no. 12, pp. 1664–1675, 2004. View at Publisher · View at Google Scholar
  23. M. A. Lowes, A. M. Bowcock, and J. G. Krueger, “Pathogenesis and therapy of psoriasis,” Nature, vol. 445, no. 7130, pp. 866–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Arango Duque and A. Descoteaux, “Macrophage cytokines: involvement in immunity and infectious diseases,” Frontiers in Immunology, vol. 5, p. 491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. L. Karnovsky, “Metchnikoff in Messina: a century of studies on phagocytosis,” The New England Journal of Medicine, vol. 304, no. 19, pp. 1178–1180, 1981. View at Publisher · View at Google Scholar
  26. T. M. Doherty, “T-cell regulation of macrophage function,” Current Opinion in Immunology, vol. 7, no. 3, pp. 400–404, 1995. View at Google Scholar
  27. R. Mirza, L. A. DiPietro, and T. J. Koh, “Selective and specific macrophage ablation is detrimental to wound healing in mice,” The American Journal of Pathology, vol. 175, no. 6, pp. 2454–2462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. J. Leibovich and R. Ross, “The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum,” The American Journal of Pathology, vol. 78, no. 1, pp. 71–100, 1975. View at Google Scholar
  29. T. Lucas, A. Waisman, R. Ranjan et al., “Differential roles of macrophages in diverse phases of skin repair,” Journal of Immunology, vol. 184, no. 7, pp. 3964–3977, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. S. Koh, B. B. Majewski, and E. L. Rhodes, “Increased macrophage activity in psoriasis,” Acta Dermato-Venereologica, vol. 65, no. 3, pp. 194–198, 1985. View at Google Scholar
  31. J. Fuentes-Duculan, M. Suarez-Farinas, L. C. Zaba et al., “A subpopulation of CD163-positive macrophages is classically activated in psoriasis,” The Journal of Investigative Dermatology, vol. 130, no. 10, pp. 2412–2422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. S. Taams, L. W. Poulter, M. H. Rustin, and A. N. Akbar, “Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7,” Pathobiology, vol. 67, no. 5-6, pp. 249–252, 2000. View at Publisher · View at Google Scholar
  33. K. Micklem, E. Rigney, J. Cordell et al., “A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies,” British Journal of Haematology, vol. 73, no. 1, pp. 6–11, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Weber-Matthiesen and W. Sterry, “Organization of the monocyte/macrophage system of normal human skin,” The Journal of Investigative Dermatology, vol. 95, no. 1, pp. 83–89, 1990. View at Publisher · View at Google Scholar
  35. B. K. Min, K. Suk, and W. H. Lee, “Stimulation of CD107 affects LPS-induced cytokine secretion and cellular adhesion through the ERK signaling pathway in the human macrophage-like cell line, THP-1,” Cellular Immunology, vol. 281, no. 2, pp. 122–128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. L. Eskelinen, “Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy,” Molecular Aspects of Medicine, vol. 27, no. 5-6, pp. 495–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Elomaa, M. Kangas, C. Sahlberg et al., “Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages,” Cell, vol. 80, no. 4, pp. 603–609, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Kzhyshkowska, “Multifunctional receptor stabilin-1 in homeostasis and disease,” Scientific World Journal, vol. 10, pp. 2039–2053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Goerdt, R. Bhardwaj, and C. Sorg, “Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro,” The American Journal of Pathology, vol. 142, no. 5, pp. 1409–1422, 1993. View at Google Scholar
  40. V. Kodelja and S. Goerdt, “Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro,” Experimental Dermatology, vol. 3, no. 6, pp. 257–268, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Egawa, K. Mukai, S. Yoshikawa et al., “Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4,” Immunity, vol. 38, no. 3, pp. 570–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Vestergaard, H. Just, J. Baumgartner Nielsen, K. Thestrup-Pedersen, and M. Deleuran, “Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis,” Acta Dermato-Venereologica, vol. 84, no. 5, pp. 353–358, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Gratchev, J. Kzhyshkowska, K. Kothe et al., “Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals,” Immunobiology, vol. 211, no. 6–8, pp. 473–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Wang, T. Peters, D. Kess et al., “Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2105–2114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Stratis, M. Pasparakis, R. A. Rupec et al., “Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2094–2104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. A. Clark and T. S. Kupper, “Misbehaving macrophages in the pathogenesis of psoriasis,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2084–2087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Morimura, T. Oka, M. Sugaya, and S. Sato, “CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages,” Journal of Dermatological Science, vol. 82, no. 3, pp. 175–188, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. J. A. Wolfram, D. Diaconu, D. A. Hatala et al., “Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis,” The American Journal of Pathology, vol. 174, no. 4, pp. 1443–1458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. N. L. Ward, C. M. Loyd, J. A. Wolfram, D. Diaconu, C. M. Michaels, and T. S. McCormick, “Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice,” The British Journal of Dermatology, vol. 164, no. 4, pp. 750–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Terhorst, R. Chelbi, C. Wohn et al., “Dynamics and transcriptomics of skin dendritic cells and macrophages in an imiquimod-induced, biphasic mouse model of psoriasis,” Journal of Immunology, vol. 195, no. 10, pp. 4953–4961, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. A. B. Wysocki, “Skin anatomy, physiology, and pathophysiology,” The Nursing Clinics of North America, vol. 34, no. 4, pp. 777–797, 1999. View at Google Scholar
  52. J. Kanitakis, “Anatomy, histology and immunohistochemistry of normal human skin,” European Journal of Dermatology, vol. 12, no. 4, pp. 390–399, 2002. View at Google Scholar
  53. E. Glitzner, A. Korosec, P. M. Brunner et al., “Specific roles for dendritic cell subsets during initiation and progression of psoriasis,” EMBO Molecular Medicine, vol. 6, no. 10, pp. 1312–1327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Leite Dantas, D. Masemann, T. Schied et al., “Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes,” The Journal of Pathology, vol. 240, no. 3, pp. 366–377, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Zhang, Y. Lin, C. Li et al., “IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1/M2 macrophage ratio in psoriasis,” Journal of Immunology, vol. 197, no. 6, pp. 2131–2144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. X. Teng, Z. Hu, X. Wei et al., “IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production,” Journal of Immunology, vol. 192, no. 4, pp. 1815–1823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. F. Nold, C. A. Nold-Petry, J. A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello, “IL-37 is a fundamental inhibitor of innate immunity,” Nature Immunology, vol. 11, no. 11, pp. 1014–1022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Kolaczkowska and P. Kubes, “Neutrophil recruitment and function in health and inflammation,” Nature Reviews. Immunology, vol. 13, no. 3, pp. 159–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. G. B. Segel, M. W. Halterman, and M. A. Lichtman, “The paradox of the neutrophil’s role in tissue injury,” Journal of Leukocyte Biology, vol. 89, no. 3, pp. 359–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. B. G. Yipp and P. Kubes, “NETosis: how vital is it?” Blood, vol. 122, no. 16, pp. 2784–2794, 2013. View at Publisher · View at Google Scholar
  61. M. Schon, D. Denzer, R. C. Kubitza, T. Ruzicka, and M. P. Schon, “Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice,” The Journal of Investigative Dermatology, vol. 114, no. 5, pp. 976–983, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Peveri, A. Walz, B. Dewald, and M. Baggiolini, “A novel neutrophil-activating factor produced by human mononuclear phagocytes,” The Journal of Experimental Medicine, vol. 167, no. 5, pp. 1547–1559, 1988. View at Publisher · View at Google Scholar
  63. B. Moser, C. Schumacher, V. von Tscharner, I. Clark-Lewis, and M. Baggiolini, “Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils,” The Journal of Biological Chemistry, vol. 266, no. 16, pp. 10666–10671, 1991. View at Google Scholar
  64. P. V. Afonso, M. Janka-Junttila, Y. J. Lee et al., “LTB4 is a signal-relay molecule during neutrophil chemotaxis,” Developmental Cell, vol. 22, no. 5, pp. 1079–1091, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. E. S. Van Amersfoort, T. J. Van Berkel, and J. Kuiper, “Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock,” Clinical Microbiology Reviews, vol. 16, no. 3, pp. 379–414, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. O. Chertov, D. F. Michiel, L. Xu et al., “Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils,” The Journal of Biological Chemistry, vol. 271, no. 6, pp. 2935–2940, 1996. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Ikeda, H. Takahashi, Y. Suga et al., “Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis,” Journal of the American Academy of Dermatology, vol. 68, no. 4, pp. 609–617, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. P. C. Res, G. Piskin, O. J. de Boer et al., “Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis,” PLoS One, vol. 5, no. 11, article e14108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. R. R. Keijsers, A. G. Hendriks, P. E. van Erp et al., “In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17,” The Journal of Investigative Dermatology, vol. 134, no. 5, pp. 1276–1284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Reich, K. A. Papp, R. T. Matheson et al., “Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis,” Experimental Dermatology, vol. 24, no. 7, pp. 529–535, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. A. M. Lin, C. J. Rubin, R. Khandpur et al., “Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis,” Journal of Immunology, vol. 187, no. 1, pp. 490–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Sumida, K. Yanagida, Y. Kita et al., “Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis,” Journal of Immunology, vol. 192, no. 9, pp. 4361–4369, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Li, L. Huang, A. L. Vergis et al., “IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury,” The Journal of Clinical Investigation, vol. 120, no. 1, pp. 331–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. S. C. Liang, X. Y. Tan, D. P. Luxenberg et al., “Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides,” The Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. K. E. Nograles, L. C. Zaba, E. Guttman-Yassky et al., “Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways,” The British Journal of Dermatology, vol. 159, no. 5, pp. 1092–1102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Peric, S. Koglin, S. M. Kim et al., “IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes,” Journal of Immunology, vol. 181, no. 12, pp. 8504–8512, 2008. View at Publisher · View at Google Scholar
  77. K. El Malki, S. H. Karbach, J. Huppert et al., “An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling,” The Journal of Investigative Dermatology, vol. 133, no. 2, pp. 441–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. A. L. Croxford, S. Karbach, F. C. Kurschus et al., “IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions,” The Journal of Investigative Dermatology, vol. 134, no. 3, pp. 728–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. G. S. Garcia-Romo, S. Caielli, B. Vega et al., “Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus,” Science Translational Medicine, vol. 3, no. 73, p. 73ra20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Lande, E. Botti, C. Jandus et al., “The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis,” Nature Communications, vol. 5, p. 5621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. N. A. Cicco, A. Lindemann, J. Content et al., “Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha,” Blood, vol. 75, no. 10, pp. 2049–2052, 1990. View at Google Scholar
  82. D. B. Dubravec, D. R. Spriggs, J. A. Mannick, and M. L. Rodrick, “Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha,” Proceedings of the National Academy of Sciences, vol. 87, no. 17, pp. 6758–6761, 1990. View at Publisher · View at Google Scholar
  83. E. J. Gosselin, K. Wardwell, W. F. Rigby, and P. M. Guyre, “Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3,” Journal of Immunology, vol. 151, no. 3, pp. 1482–1490, 1993. View at Google Scholar
  84. A. Matsukawa and M. Yoshinaga, “Neutrophils as a source of cytokines in inflammation,” Histology and Histopathology, vol. 14, no. 2, pp. 511–516, 1999. View at Google Scholar
  85. E. Glowacka, P. Lewkowicz, H. Rotsztejn, and A. Zalewska, “IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis,” Advances in Medical Sciences, vol. 55, no. 2, pp. 254–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Uribe-Herranz, L. H. Lian, K. M. Hooper, K. A. Milora, and L. E. Jensen, “IL-1R1 signaling facilitates Munro’s microabscess formation in psoriasiform imiquimod-induced skin inflammation,” The Journal of Investigative Dermatology, vol. 133, no. 6, pp. 1541–1549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Rahmoun, J. P. Moles, N. Pedretti et al., “Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils,” The Journal of Investigative Dermatology, vol. 129, no. 3, pp. 671–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. X. Xue, P. Soroosh, A. De Leon-Tabaldo et al., “Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis,” Scientific Reports, vol. 6, article 37977, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. I. Khmaladze, T. Kelkka, S. Guerard et al., “Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice,” Proceedings of the National Academy of Sciences, vol. 111, no. 35, pp. E3669–E3678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. H. Watanabe, M. Kawaguchi, S. Fujishima et al., “Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis,” The Journal of Investigative Dermatology, vol. 129, no. 3, pp. 650–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Yamanaka, Y. Umezawa, A. Yamagiwa et al., “Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils,” The Journal of Dermatology, vol. 41, no. 8, pp. 679–685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. B. J. Nickoloff, S. L. Kunkel, M. Burdick, and R. M. Strieter, “Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model,” The American Journal of Pathology, vol. 146, no. 3, pp. 580–588, 1995. View at Google Scholar
  93. A. Gilhar, M. David, Y. Ullmann, T. Berkutski, and R. S. Kalish, “T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice,” The Journal of Investigative Dermatology, vol. 109, no. 3, pp. 283–288, 1997. View at Publisher · View at Google Scholar
  94. S. Guerrero-Aspizua, M. Garcia, R. Murillas et al., “Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways,” The American Journal of Pathology, vol. 177, no. 6, pp. 3112–3124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Del Rio, F. Larcher, F. Serrano et al., “A preclinical model for the analysis of genetically modified human skin in vivo,” Human Gene Therapy, vol. 13, no. 8, pp. 959–968, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Bracke, M. Carretero, S. Guerrero-Aspizua et al., “Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies,” Experimental Dermatology, vol. 23, no. 3, pp. 199–201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Jean, M. Lapointe, J. Soucy, and R. Pouliot, “Development of an in vitro psoriatic skin model by tissue engineering,” Journal of Dermatological Science, vol. 53, no. 1, pp. 19–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Tjabringa, M. Bergers, D. van Rens, R. de Boer, E. Lamme, and J. Schalkwijk, “Development and validation of human psoriatic skin equivalents,” The American Journal of Pathology, vol. 173, no. 3, pp. 815–823, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Pouliot-Berube, K. Zaniolo, S. L. Guerin, and R. Pouliot, “Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis,” Regenerative Medicine, vol. 11, no. 6, pp. 545–557, 2016. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Carretero, S. Guerrero-Aspizua, N. Illera et al., “Differential features between chronic skin inflammatory diseases revealed in skin-humanized psoriasis and atopic dermatitis mouse models,” The Journal of Investigative Dermatology, vol. 136, no. 1, pp. 136–145, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Gazel, M. Rosdy, B. Bertino, C. Tornier, F. Sahuc, and M. Blumenberg, “A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis,” The Journal of Investigative Dermatology, vol. 126, no. 12, pp. 2647–2657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Dezutter-Dambuyant, A. Black, N. Bechetoille et al., “Evolutive skin reconstructions: from the dermal collagen– glycosaminoglycan– chitosane substrate to an immunocompetent reconstructed skin,” Bio-medical Materials and Engineering, vol. 16, Supplement 4, pp. S85–S94, 2006. View at Google Scholar
  103. D. Y. Chau, C. Johnson, S. MacNeil, J. W. Haycock, and A. M. Ghaemmaghami, “The development of a 3D immunocompetent model of human skin,” Biofabrication, vol. 5, no. 3, article 035011, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Bechetoille, H. Vachon, A. Gaydon et al., “A new organotypic model containing dermal-type macrophages,” Experimental Dermatology, vol. 20, no. 12, pp. 1035–1037, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. E. H. van den Bogaard, G. S. Tjabringa, I. Joosten et al., “Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases,” The Journal of Investigative Dermatology, vol. 134, no. 3, pp. 719–727, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. H. Pageon, H. Zucchi, F. Rousset, S. Girardeau-Hubert, E. Tancrede, and D. Asselineau, “Glycation stimulates cutaneous monocyte differentiation in reconstructed skin in vitro,” Mechanisms of Ageing and Development, vol. 162, pp. 18–26, 2017. View at Publisher · View at Google Scholar
  107. D. G. Nguyen, J. Funk, J. B. Robbins et al., “Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro,” PLoS One, vol. 11, no. 7, article e0158674, 2016. View at Publisher · View at Google Scholar · View at Scopus
  108. C. Maier, A. Ramming, C. Bergmann et al., “Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages,” Annals of the Rheumatic Diseases, vol. 76, 2017. View at Publisher · View at Google Scholar
  109. H. Bessar, I. Venditti, L. Benassi et al., “Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis,” Colloids and Surfaces. B, Biointerfaces, vol. 141, pp. 141–147, 2016. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Ramezanli, B. E. Kilfoyle, Z. Zhang, and B. B. Michniak-Kohn, “Polymeric nanospheres for topical delivery of vitamin D3,” International Journal of Pharmaceutics, vol. 516, no. 1-2, pp. 196–203, 2017. View at Publisher · View at Google Scholar
  111. C. L. Barker, M. T. McHale, A. K. Gillies et al., “The development and characterization of an in vitro model of psoriasis,” Journal of Investigative Dermatology, vol. 123, no. 5, pp. 892–901, 2004. View at Google Scholar